Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

ILC1-like cells can cause alopecia areata by themselves.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

FOXN1 is crucial for thymus development and immune response in Xenopus laevis.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Four botanical extracts were found to quickly attract neutrophils to wounded skin in zebrafish.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

FoxN1 overexpression in young mice harms immune cell and skin development.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Early over-expression of FoxN1 harms immune and skin development.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.